查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1908648

gRNA市場規模、佔有率和趨勢分析報告：按產品/服務、gRNA類型、應用、最終用途、地區和細分市場預測（2025-2033年）

gRNA Market Size, Share & Trends Analysis Report By Product & Service (Products, Custom gRNA Synthesis Services), By gRNA Type (Research-use, GPM-grade), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

gRNA市場概況

2024年全球gRNA市場規模估計為5.795億美元，預計2033年將達到26.6億美元。

預計從 2025 年到 2033 年，gRNA 將以 18.64% 的複合年成長率成長。由於 gRNA 是基於 CRISPR 的基因編輯所必需的，因此需求量很大。

將 CRISPR 系統精確靶向特定 DNA 序列的能力，能夠實現精確的基因改造，從而推動醫學、農業和生物技術領域的突破。

CRISPR基因編輯技術的應用範圍不斷擴大

從科學研究到工業，CRISPR應用範圍的快速擴展正推動全球對gRNA的需求激增。作為將CRISPR靶向特定DNA或RNA的關鍵組成部分，所有CRISPR工作流程都依賴精準可靠的gRNA。 CRISPR在功能基因組學、基因敲除/敲入研究、基因修飾細胞模型和高通量篩檢等領域的日益廣泛應用，顯著推動了客製化gRNA消費量的成長。隨著CRISPR技術從科學研究走向臨床和治療應用，尤其是在基因治療和精準醫療領域，越來越多的生物製藥公司和學術實驗室開始採用這項技術，進一步增加了對專用gRNA的需求。例如，2021年10月，德國默克公司將其取得專利的CRISPR-Cas9技術授權給Cellecta公司，從而推動了先進的基因敲入應用。

CRISPR系統的日益多樣化推動了對客製化gRNA產品的需求。隨著基因編輯技術從傳統的Cas9發展到用於RNA標靶化和小型化遞送的下一代工具（如Cas12和Cas13），以及鹼基編輯和先導編輯等​​平台，研究人員需要高效且脫靶效應最小的最佳化gRNA。

目錄

第1章調查方法和範圍

第2章：gRNA市場：執行摘要

  • 市場展望
  • 細分市場概覽
  • 競爭格局概述

第3章 gRNA市場變數和趨勢

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關及輔助市場展望
  • 市場動態
  • 市場促進因素分析
    • CRISPR基因編輯技術的應用範圍不斷擴大
    • 擴大蛋白質體學和基因組學領域的研究與開發
  • 市場限制因素分析
    • 監管挑戰
    • 脫靶效應與安全性問題
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

第4章：按產品和服務分類的估算和趨勢分析

  • gRNA市場：按產品和服務分類的差異分析
  • 產品
    • 產品市場估算與預測，2021-2033年
    • 最終產品
    • gRNA合成產物
  • 客製化gRNA合成服務
    • 客製化gRNA合成服務市場估算與預測，2021-2033年

第5章 按gRNA類型進行的估計和趨勢分析

  • gRNA市場：按gRNA類型分類的差異分析
  • 研究用途
    • 研究應用市場收入估計與預測，2021-2033年
  • GMP級
    • GMP級產品市場收入估算及預測，2021-2033年

第6章 應用估算與趨勢分析

  • gRNA市場：按應用分類的差異分析
  • 基因組工程
    • 基因組工程市場收入估算與預測，2021-2033年
  • 疾病模型研究
    • 疾病建模研究市場收入估算與預測，2021-2033年
  • 功能基因體學
    • 功能基因體學市場收入估計與預測，2021-2033年
  • 表觀遺傳學
    • 表觀遺傳學市場收入估算與預測，2021-2033年
  • 其他
    • 其他市場收入估算與預測，2021-2033年

第7章 依最終用途估算與趨勢分析

  • gRNA市場：依最終用途分類的差異分析
  • 製藥和生物技術公司
    • 2021-2033年醫藥和生物技術市場收入估計和預測
  • 學術研究機構
    • 學術研究機構市場收入估算與預測，2021-2033年
  • 合約生產組織 (CMO) 和合約研究組織 (CRO)
    • 2021-2033年CMO和CRO市場收入估算與預測

第8章：區域商業分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 北美gRNA市場估算與預測，2021-2033年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲 gRNA 市場，2021-2033
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區gRNA市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 2021-2033年拉丁美洲gRNA市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲gRNA市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
  • 2024年市場分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc
    • Agilent Technologies, Inc.
    • System Biosciences, LLC.
    • Jena Bioscience GmbH
    • Merck KGaA
    • Azenta Life Sciences（Genewiz）
    • Takara Bio Inc.
    • Synbio Technologies
    • Revvity Inc（Horizon Discovery Ltd.）
    • Synthego
Product Code: GVR-4-68040-180-5

gRNA Market Summary

The global gRNA market size was estimated at USD 579.5 million in 2024 and is projected to reach USD 2.66 billion by 2033, growing at a CAGR of 18.64% from 2025 to 2033. gRNA is in high demand because it is essential for CRISPR-based genetic editing.

Its ability to accurately guide the CRISPR system to specific DNA sequences enables precise gene modifications, driving breakthroughs in medicine, agriculture, and biotechnology.

Expansion of CRISPR Gene Editing Applications

The global demand for gRNA is rising sharply due to the rapid expansion of CRISPR applications across research and industry. As the critical element that directs CRISPR to specific DNA or RNA targets, every CRISPR workflow depends on precise and reliable gRNA. Increasing use of CRISPR in functional genomics, knockout/knock-in studies, engineered cell models, and high-throughput screening has driven strong growth in customized gRNA consumption. With CRISPR advancing from research to clinical and therapeutic applications, especially in gene therapy and precision medicine, more biopharma and academic labs are adopting the technology, further escalating the need for specialized gRNA. For instance, in October 2021, in Germany, Merck licensed its patented CRISPR-Cas9 technology to Cellecta, enabling advanced knock-in applications.

The growing diversification of CRISPR systems is further boosting demand for tailored gRNA products. As gene-editing advances from traditional Cas9 to next-generation tools like Cas12 and Cas13 for RNA targeting, for compact delivery, and platforms such as base and prime editing, researchers require highly optimized gRNAs with greater efficiency and minimal off-target effects.

Global gRNA Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global gRNA market report based on product & services, gRNA type, application, end-use, and region:

  • Product & Service Outlook (Revenue in USD Million, 2021 - 2033)
  • Products
    • gRNA Final Products
    • gRNA Synthesis Products
    • gRNA Synthesis Kits
    • Plasmids
    • Others
  • Custom gRNA Synthesis Services
  • gRNA Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Research-Use
  • GMP-grade
  • Application Outlook (Revenue, USD Million; 2021 - 2033)
  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others
  • End-use Outlook (Revenue, USD Million; 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • CMOs & CROs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. gRNA Type
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. gRNA Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. gRNA Market Variables and Trends

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Expansion of CRISPR gene editing applications
    • 3.4.2. Growing R&D in proteomics and genomics
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory Challenges
    • 3.5.2. Off-Target Effects and Safety Concerns
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis

Chapter 4. Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. gRNA market: Product & Service Movement Analysis
  • 4.3. Products
    • 4.3.1. Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. gRNA Final Products
      • 4.3.2.1. gRNA Final Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. gRNA Synthesis Products
      • 4.3.3.1. gRNA Synthesis Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. gRNA Synthesis Kits
        • 4.3.3.2.1. gRNA Synthesis Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Plasmids
        • 4.3.3.3.1. Plasmids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.4. Others
        • 4.3.3.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Custom gRNA Synthesis Services
    • 4.4.1. Custom gRNA Synthesis Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. gRNA Type Estimates & Trend Analysis

  • 5.1. gRNA Type Segment Dashboard
  • 5.2. gRNA market: gRNA Type Movement Analysis
  • 5.3. Research-Use
    • 5.3.1. Research-Use Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. GMP-grade
    • 5.4.1. GMP-grade Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. gRNA market: Application Movement Analysis
  • 6.3. Genome Engineering
    • 6.3.1. Genome Engineering Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Disease Model Studies
    • 6.4.1. Disease Model Studies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Functional Genomics
    • 6.5.1. Functional Genomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Epigenetics
    • 6.6.1. Epigenetics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. gRNA market: End-Use Movement Analysis
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Academic Research Institutes
    • 7.4.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. CMOs & CROs
    • 7.5.1. CMOs & CROs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. North America gRNA Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. U.S. gRNA Market, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Canada gRNA Market, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. Mexico gRNA Market, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. UK gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Germany gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.4. Spain
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Spain gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.5. France
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. France gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.6. Italy
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Target Disease Prevalence
      • 8.5.6.5. Italy gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Target Disease Prevalence
      • 8.5.7.5. Denmark gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Target Disease Prevalence
      • 8.5.8.5. Sweden gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Target Disease Prevalence
      • 8.5.9.5. Norway gRNA Market, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia-Pacific gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Target Disease Prevalence
      • 8.6.2.5. Japan gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. China gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. India gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. South Korea gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Target Disease Prevalence
      • 8.6.6.5. Thailand gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.7. Australia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Target Disease Prevalence
      • 8.6.7.5. Australia gRNA Market, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America gRNA Market, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Target Disease Prevalence
      • 8.7.2.5. Brazil gRNA Market, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Target Disease Prevalence
      • 8.7.3.5. Argentina gRNA Market, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Target Disease Prevalence
      • 8.8.2.5. South Africa gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Target Disease Prevalence
      • 8.8.3.5. Saudi Arabia gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Target Disease Prevalence
      • 8.8.4.5. UAE gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Target Disease Prevalence
      • 8.8.5.5. Kuwait gRNA Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Market Position Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Agilent Technologies, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. System Biosciences, LLC.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Jena Bioscience GmbH
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Merck KGaA
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Azenta Life Sciences (Genewiz)
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Benchmarking
      • 9.4.6.3. Strategic Initiatives
    • 9.4.7. Takara Bio Inc.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Synbio Technologies
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Revvity Inc (Horizon Discovery Ltd.)
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Synthego
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Market Research Process
  • TABLE 2 Information Procurement
  • TABLE 3 Primary Research Pattern
  • TABLE 4 Market Research Approaches
  • TABLE 5 Value Chain-Based Sizing & Forecasting
  • TABLE 6 Market Formulation & Validation
  • TABLE 7 gRNA market Segmentation
  • TABLE 8 Market Snapshot, 2024
  • TABLE 9 Market Trends & Outlook
  • TABLE 10 Market Driver Relevance Analysis (Current & Future Impact)
  • TABLE 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • TABLE 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • TABLE 13 Porter's Five Forces Analysis
  • TABLE 14 Global gRNA market: Product & Service Movement Analysis
  • TABLE 15 Global gRNA market, for Products, 2021 - 2033 (USD Million)
  • TABLE 16 Global gRNA market, for gRNA Final Products, 2021 - 2033 (USD Million)
  • TABLE 17 Global gRNA market, for gRNA Synthesis Products, 2021 - 2033 (USD Million)
  • TABLE 18 Global gRNA market, for gRNA Synthesis Kits, 2021 - 2033 (USD Million)
  • TABLE 19 Global gRNA market, for Plasmids, 2021 - 2033 (USD Million)
  • TABLE 20 Global gRNA market, for Others, 2021 - 2033 (USD Million)
  • TABLE 21 Global gRNA market, for Custom gRNA Synthesis Services, 2021 - 2033 (USD Million)
  • TABLE 22 Global gRNA market: gRNA Type Movement Analysis
  • TABLE 23 Global gRNA market, for Research-Use, 2021 - 2033 (USD Million)
  • TABLE 24 Global gRNA market, for GMP-grade, 2021 - 2033 (USD Million)
  • TABLE 25 Global gRNA market: Application Movement Analysis
  • TABLE 26 Global gRNA market, for Genome Engineering, 2021 - 2033 (USD Million)
  • TABLE 27 Global gRNA market, for Disease Model Studies, 2021 - 2033 (USD Million)
  • TABLE 28 Global gRNA market, for Functional Genomics, 2021 - 2033 (USD Million)
  • TABLE 29 Global gRNA market, for Epigenetics, 2021 - 2033 (USD Million)
  • TABLE 30 Global gRNA market, for Others, 2021 - 2033 (USD Million)
  • TABLE 31 Global gRNA market: End Use Movement Analysis
  • TABLE 32 Global gRNA market, for Pharmaceutical & Biotechnology Companies, 2021 - 2033 (USD Million)
  • TABLE 33 Global gRNA market, for Academic Research Institutes, 2021 - 2033 (USD Million)
  • TABLE 34 Global gRNA market, for CMOs & CROs, 2021 - 2033 (USD Million)
  • TABLE 35 Regional Marketplace: Key Takeaways
  • TABLE 36 Regional Outlook, 2023 & 2033
  • TABLE 37 Global gRNA market: Region Movement Analysis
  • TABLE 38 North America gRNA market, 2021 - 2033 (USD Million)
  • TABLE 39 U.S. gRNA market, 2021 - 2033 (USD Million)
  • TABLE 40 Canada gRNA market, 2021 - 2033 (USD Million)
  • TABLE 41 Mexico gRNA market, 2021 - 2033 (USD Million)
  • TABLE 42 Europe gRNA market, 2021 - 2033 (USD Million)
  • TABLE 43 Germany gRNA market, 2021 - 2033 (USD Million)
  • TABLE 44 UK gRNA market, 2021 - 2033 (USD Million)
  • TABLE 45 France gRNA market, 2021 - 2033 (USD Million)
  • TABLE 46 Italy gRNA market, 2021 - 2033 (USD Million)
  • TABLE 47 Spain gRNA market, 2021 - 2033 (USD Million)
  • TABLE 48 Denmark gRNA market, 2021 - 2033 (USD Million)
  • TABLE 49 Sweden gRNA market, 2021 - 2033 (USD Million)
  • TABLE 50 Norway gRNA market, 2021 - 2033 (USD Million)
  • TABLE 51 Asia Pacific gRNA market, 2021 - 2033 (USD Million)
  • TABLE 52 Japan gRNA market, 2021 - 2033 (USD Million)
  • TABLE 53 China gRNA market, 2021 - 2033 (USD Million)
  • TABLE 54 India gRNA market, 2021 - 2033 (USD Million)
  • TABLE 55 Australia gRNA market, 2021 - 2033 (USD Million)
  • TABLE 56 South Korea gRNA market, 2021 - 2033 (USD Million)
  • TABLE 57 Thailand gRNA market, 2021 - 2033 (USD Million)
  • TABLE 58 Latin America gRNA market, 2021 - 2033 (USD Million)
  • TABLE 59 Brazil gRNA market, 2021 - 2033 (USD Million)
  • TABLE 60 Argentina gRNA market, 2021 - 2033 (USD Million)
  • TABLE 61 Middle East and Africa gRNA market, 2021 - 2033 (USD Million)
  • TABLE 62 South Africa gRNA market, 2021 - 2033 (USD Million)
  • TABLE 63 Saudi Arabia gRNA market, 2021 - 2033 (USD Million)
  • TABLE 64 UAE gRNA market, 2021 - 2033 (USD Million)
  • TABLE 65 Kuwait gRNA market, 2021 - 2033 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Market formulation & validation
  • FIG. 4 gRNA market: Market outlook
  • FIG. 5 gRNA market: Segment outlook
  • FIG. 6 gRNA market: Competitive landscape outlook
  • FIG. 7 Parent market outlook
  • FIG. 8 gRNA market driver impact
  • FIG. 9 gRNA market restraint impact
  • FIG. 10 gRNA market: Product & Service outlook and key takeaways
  • FIG. 11 gRNA market: Product & Service movement analysis
  • FIG. 12 Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 13 gRNA Final Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 14 gRNA Synthesis Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 15 gRNA Synthesis Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 16 Plasmids market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 17 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 18 Custom gRNA Synthesis Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 19 gRNA market: gRNA Type outlook and key takeaways
  • FIG. 20 gRNA market: gRNA Type movement analysis
  • FIG. 21 Research-Use market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 22 GMP-grade market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 23 gRNA market: Application outlook and key takeaways
  • FIG. 24 gRNA market: Application movement analysis
  • FIG. 25 Genome Engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 26 Disease Model Studies market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 27 Functional Genomics market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 28 Epigenetics market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 29 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 30 gRNA market: End use outlook and key takeaways
  • FIG. 31 gRNA market: End use movement analysis
  • FIG. 32 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 33 Pharmaceutical & biotechnology companies market estimates and forecasts,2021 - 2033 (USD Million)
  • FIG. 34 CMOs & CROs market estimates and forecasts,2021 - 2033 (USD Million)
  • FIG. 35 Global gRNA market: Regional outlook and key takeaways
  • FIG. 36 Global gRNA market: Regional movement analysis
  • FIG. 37 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 38 Key country dynamics
  • FIG. 39 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 40 Key country dynamics
  • FIG. 41 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 42 Key country dynamics
  • FIG. 43 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 44 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 45 Key country dynamics
  • FIG. 46 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 47 Key country dynamics
  • FIG. 48 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 49 Key country dynamics
  • FIG. 50 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 51 Key country dynamics
  • FIG. 52 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 53 Key country dynamics
  • FIG. 54 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 55 Key country dynamics
  • FIG. 56 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 57 Key country dynamics
  • FIG. 58 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 59 Key country dynamics
  • FIG. 60 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 61 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 62 Key country dynamics
  • FIG. 63 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 64 Key country dynamics
  • FIG. 65 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 66 Key country dynamics
  • FIG. 67 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 68 Key country dynamics
  • FIG. 69 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 70 Key country dynamics
  • FIG. 71 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 72 Key country dynamics
  • FIG. 73 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 74 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 75 Key country dynamics
  • FIG. 76 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 77 Key country dynamics
  • FIG. 78 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 79 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 80 Key country dynamics
  • FIG. 81 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 82 Key country dynamics
  • FIG. 83 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 84 Key country dynamics
  • FIG. 85 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 86 Key country dynamics
  • FIG. 87 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)